Zurueck zur Suche

Reporte zur Charge U022316

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

19Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NV 4 MD 2 TX 2 CA 1 OR 1 MA 1 MT 1 IL 1 WV 1 GA 1 NM 1 WA 1

VAERS 2557536

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022316

schwer
Staat
CA
Alter
17,0
Geschlecht
M
Eingang
11.01.2023
Impfdatum
10.01.2023
Beginn
10.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Hyperhidrosis Lethargy Muscle spasms Pain in extremity Pallor Presyncope Seizure Seizure like phenomena Tuberculin test

Symptomtext

On 01/10/2023 10:50am 17y/o male patient received 5 injections, Polio, Varicella, T-Dap, MMR and Hepatitis B with PPD. Patient tolerated first 3 vaccinations on the left arm well. Last 2 vaccinations were given on the right arm. PPD was place on the right forearm with complaint of pain but was tolerating well. Patient remained sitting while LVN went to print out the shot record. LVN was standing by the copying machine less than 3 feet away from the exam room with door open. Approximately around 10:55am, patient ?s brother called for help. With exam door open LVN observed patient had seizure like symptom, characterize by convulsing, diaphoresis, closing of eyes and pallor. Convulsion was less than 5 seconds, by the time LVN was in the exam room and beside the patient, muscle spasming has already stopped. LVN called for help immediately and advised patient to breathe through his nose and out through his mouth. Oxygen was given @2L/min via nasal canula. Patient was conscious and responsive. 11:00am LVN went to call Dr for assessment. Dr confirmed that it was vasovagal response and advise that patient could leave once he is able to walk with feeling dizzy. BP was taken every 5 minutes. 100/68 @11:00am. Patient was alert and oriented however, appear lethargic, pale and diaphoretic. Lollipop and Kool-Aid 6.75fl oz was given. After further discussion, patient?s brother stated that the patient has not eaten breakfast/lunch. At 11:07am BP 108/70, O2 was 99% on 2L/min via nasal canula. Color returned and patient stated that he?d felt better with slight dizziness. Patient drank water. BP taken @11:15am 110/72 with O2 discontinued. 11:20am BP 120/78 O2 99% and left the exam ambulating independently. Before leaving LVN advised patient?s brother and father to make sure that patient eats. if further complication arises to take patient to the ER. Patient is scheduled to return on Thursday 01/12/2023 for PPD reading. 01/10/2023 LVN

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
-
Labordaten
NO
Aktuelle Erkrankungen
NO
Vorgeschichte
NO
Andere Medikamente
NO; MANTOUX
Allergien
NO
Vorherige Impfungen
-

VAERS 2640321

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022316

mild
Staat
OR
Alter
1,0
Geschlecht
M
Eingang
02.06.2023
Impfdatum
01.06.2023
Beginn
01.06.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site swelling

Symptomtext

Localized redness and swelling around the injection site. Ice applied.to reaction site

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2490135

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge u022316

mild
Staat
MA
Alter
1,0
Geschlecht
F
Eingang
26.10.2022
Impfdatum
18.10.2022
Beginn
23.10.2022
Tage bis Beginn
5,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Decreased appetite Dermatitis acneiform Pyrexia Rash erythematous Tenderness

Symptomtext

Fever started 3 days ago, red area with 4 tiny pimples inside, very painful to touch. Physician prescribed po Bactrim today and return precautions. No other symptoms per Mom besides decreased appetite since yesterday.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
BRONCHITIS
Vorgeschichte
ASTHMA
Andere Medikamente
ALBUTEROL SINGULAIR PULMICORT
Allergien
NKA
Vorherige Impfungen
-

VAERS 2446104

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022316

mild
Staat
MT
Alter
1,0
Geschlecht
M
Eingang
15.09.2022
Impfdatum
01.09.2022
Beginn
10.09.2022
Tage bis Beginn
9,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site induration Injection site swelling Injection site warmth

Symptomtext

Red, raised indurated area developed around 2 injection sites on the left thigh. Pt. was prescribed Bactrim & Keflex in urgent care; symptoms started 9 days after injections. Redness, warmth, swelling decr. after 2 days abx.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
02/16/2020~DTaP + Hib (no brand name)~3~1.00~Sibling|02/16/2020~Pneumo (Prevnar13)~4~1.00~Sibling|02/16/2020~Measles + Mumps + R

VAERS 2716406

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022316

gering
Staat
MD
Alter
25,0
Geschlecht
U
Eingang
21.11.2023
Impfdatum
09.11.2023
Beginn
09.11.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE; Pharmacist calling to report an adverse event involving a 25 year old patient who was inadvertently administered an expired dose of MMR II. Pharmacist stated that the MMR II dose had a labeled expiration date of 7/15/2023, and was administered today; This spontaneous report was received from a pharmacist and refers to a 25-year-old patient of unknown gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 09-NOV-2023, the patient was vaccinated with an expired dose of measles, mumps, and rubella (WISTAR RA 27-3) virus vaccine, live (M-M-R II) injection, therapy type: rHA, two dose series, lot #U022316, expiration date: 15-JUL-2023, administered for prophylaxis (strength, and route of administration were not provided) (Expired product administered). Pharmacist confirmed no report of symptoms or medical concerns at this time from patient involved (No adverse event). Pharmacist stated they were unaware if the dose administered was the first dose the patient has received. No additional information provided regarding this adverse event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2712163

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022316

gering
Staat
MD
Alter
25,0
Geschlecht
F
Eingang
09.11.2023
Impfdatum
09.11.2023
Beginn
09.11.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered No adverse event

Symptomtext

The administered vaccine expired July 15 2023, upon calling the manufacturer the representative stated that according to the stability data they have for MMR II with the above expiration date, the dose is still stable and the patient doesn't need to repeat the dose. Further, upon talking to the patient, she is not experiencing or has experienced any side effects as of now.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2679032

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022316

gering
Staat
IL
Alter
-
Geschlecht
U
Eingang
04.09.2023
Impfdatum
31.08.2023
Beginn
31.08.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

No Adverse Event; Caller reported AE on behalf of an infant patient who was administered an expired dose of MMR-II (no prior TEs). No symptoms reported. Consent to contact HCP was denied. No additional AE/PQC.; This spontaneous report was received from a medical assistant refers to a infant patient of unknown gender. The patient's medical history, concurrent conditions were not reported. The patient's concomitant therapies included STERILE DILUENT. On 31-AUG-2023, the patient was vaccinated with expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live, rHA (recombinant Human albumin) (M-M-R II) lot #U022316, expiration date: 15-JUL-2023, 0.5 milliliter (route of administration and anatomical location were not reported) for prophylaxis (expired product administered).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2671687

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022316

gering
Staat
WV
Alter
-
Geschlecht
U
Eingang
16.08.2023
Impfdatum
10.08.2023
Beginn
10.08.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AEs were reported.; Medical assistant reported that an expired MMR II vaccine was given to a patient today 8/10/2023.; This spontaneous report has been received from a health care professional, regarding a patient of unknown age and gender. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported. On 10-AUG-2023, the patient was vaccinated with an expired dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) subcutaneous injection, as prophylaxis (lot number: U022316, which was determined to be valid, with an expiration date on 15-JUL-2023, therapy type: rHA), with sterile diluent (MERCK STERILE DILUENT) diluent (lot number: W000452, which was determined to be valid, with an expiration date on 23-JUL-2024) (expired product administered) (strengths, doses, schemes, routes and anatomical locations of administration were not reported). No additional event was reported. No further information was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
MERCK STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2666867

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022316

gering
Staat
NV
Alter
-
Geschlecht
U
Eingang
07.08.2023
Impfdatum
20.07.2023
Beginn
20.07.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Wrong product administered

Symptomtext

No additional AE/PQC reported.; two patients received expired MMR II vaccine; two patients received expired MMR II vaccine when they were supposed to receive a dose of PROQUAD; This spontaneous report has been received from an other healthcare professional (nurse) referring to patient with unknown gender and age. The patient's concomitant therapies, medical histories and drug allergies were not reported. On 20-JUL-2023, the patient was vaccinated with expired measles, mumps, and rubella (wistar RA 27-3) virus vaccine, live (albumin status recombinant human albumin (rHA)) (M-M-R II) subcutaneous injection, 1 dose, lot # U022316, expiration date: 15-JUL -2023, as prophylaxis (strength and route of administration was not specified), when the patient was supposed to receive a dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD)(fomulation, strength, dose, frequency, lot #, expiry date, indication and route of administration were not provided, the product was not administered) (Expired product administered) (Wrong product administered). No further information available during interaction. No additional adverse events (AEs) were reported (no adverse event), and no product quality complaints (PQCs) were reported. This is one of the two reports received from the same reporter.; Sender's Comments: US-009507513-2307USA011317:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2663044

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022316

gering
Staat
NV
Alter
-
Geschlecht
U
Eingang
31.07.2023
Impfdatum
20.07.2023
Beginn
20.07.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Wrong product administered

Symptomtext

No adverse event; two patients received expired MMR II vaccine; two patients received expired MMR II vaccine when they were supposed to receive a dose of PROQUAD; This spontaneous report was received from a registered nurse referring to an unknown age and gender patient. The patient's concurrent conditions, medical history, drug reaction or allergies and concomitant therapies were not provided. On 20-JUL-2023, the patient was administered 1 dose of expired vaccine measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live recombinant human albumin (rHA)(M-M-R II) (albumin status rHA) injection, 1 dose, (lot number U022316 has been determined to be valid for measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), expiration date reported and established as 15-JUL-2023) (strength, and route of administration were not provided), this vaccine was administered instead of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (wrong product administered). No adverse event was reported. This is one of two reports from the same reporter.; Sender's Comments: US-009507513-2307USA011531:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2660028

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022316

gering
Staat
NV
Alter
5,0
Geschlecht
F
Eingang
24.07.2023
Impfdatum
20.07.2023
Beginn
01.07.2023
Tage bis Beginn
-
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Patient administered MMRII vaccine on 7/20/23 that expired 7/15/23

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NONE
Vorherige Impfungen
-

VAERS 2659957

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022316

gering
Staat
NV
Alter
4,0
Geschlecht
F
Eingang
24.07.2023
Impfdatum
20.07.2023
Beginn
01.07.2023
Tage bis Beginn
-
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered

Symptomtext

Patient given expired (7/15/23) MMR dose on 7/20/23

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2649817

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022316

gering
Staat
GA
Alter
2,0
Geschlecht
M
Eingang
27.06.2023
Impfdatum
11.05.2023
Beginn
11.05.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Wrong product administered

Symptomtext

Kinrix vaccine given in error instead of DTAP. Error noted during monthly inventory county. Attempted to contact parent. Phone number no longer working. Alert put in child's chart.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
None needed
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None Known
Allergien
None Known
Vorherige Impfungen
-

VAERS 2578165

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022316

gering
Staat
NM
Alter
1,8
Geschlecht
F
Eingang
08.02.2023
Impfdatum
08.02.2023
Beginn
01.02.2023
Tage bis Beginn
-
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

Administered Kinrix vaccine to child aged 1 year 9 months, later staff entering paperwork informed nurse that I had admnistered a vaccine to child under recommended age,

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
UNK
Vorgeschichte
UNK
Andere Medikamente
UNK
Allergien
NO
Vorherige Impfungen
-

VAERS 2538539

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022316

gering
Staat
WA
Alter
-
Geschlecht
U
Eingang
21.12.2022
Impfdatum
28.11.2022
Beginn
28.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; Healthcare provider states improperly stored vaccine involved in a temperature excursion was administered to a patient on 28NOV2022. No additional AE reported. No PQC reported. Names of vaccines involved (including lot/exp): MMR II U022316 7/15/; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's pertinent medical history, concomitant medications, concurrent conditions, and drug reactions/allergies were not reported. On 28-NOV-2022, the patient was vaccinated with improperly stored mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant human albumin (rHA)) (M-M-R II) 1 dosage form (dosage reported as "1"), lot # U022315, expiration date 15-JUL-2023 (strength, route of administration and anatomical location were not provided) for prophylaxis (Product storage error). Administered dose of suspect vaccine experienced temperature excursion of 57.49 Fahrenheit (F) for 1 hour and 45 minutes. There was no information about previous temperature excursion and if digital data logger was involved. No additional adverse event reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2500920

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022316

gering
Staat
KS
Alter
1,0
Geschlecht
F
Eingang
07.11.2022
Impfdatum
07.11.2022
Beginn
07.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
ID / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Wrong product administered

Symptomtext

Grabbed MMR-V rather than Varicella alone

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2474323

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022316

gering
Staat
TX
Alter
-
Geschlecht
F
Eingang
11.10.2022
Impfdatum
28.09.2022
Beginn
28.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental overdose No adverse event

Symptomtext

no additional AE have been reported at the time of call.; Nurse practitioner reports an AE for MMRII and VARIVAX. Caller states a 3 year-old patient was inadvertently administered 2 doses of MMRII and 2 doses of VARIVAX concomitantly on 9/28/2022. Caller states no additional AE have been reported at the tim; This spontaneous report was received from a Nurse Practitioner, referring to a 3-year-old female patient. Information regarding medical history, concurrent conditions and concomitant medication was not provided. On 28-SEP-2022, the patient was inadvertently administered 2 doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) lot # U022316, expiration date: 15-JUL-2023, 0 .5 milliliter for prophylaxis (dosage information and route of administration not informed), and 2 doses of varicella virus vaccine live (oka/merck)(VARIVAX) 0.5 mL, Lot Number: W012164, expiration date: 12-APR-2024, for prophylaxis(dosage information and route of administration not informed); concomitantly, diluted with sterile diluent, product quantity 4, 0.5 mL (Accidental overdose). No additional adverse event had been reported at the time of call.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental overdose
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2420974

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022316

gering
Staat
TX
Alter
5,0
Geschlecht
M
Eingang
26.08.2022
Impfdatum
20.08.2022
Beginn
20.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Inappropriate schedule of product administration Wrong product administered

Symptomtext

We gave a 5 year old TDAP instead of DTAP.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2369163

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022316

gering
Staat
ME
Alter
5,0
Geschlecht
M
Eingang
14.07.2022
Impfdatum
11.05.2022
Beginn
11.05.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Poor quality product administered Product storage error

Symptomtext

Patient received a sub-optimal COVID-19 vaccine due to a storage and handling error. Vaccine was stored in a regular freezer prior to being refrigerated and then administered. The CDC requested that a VAERS form be submitted for this patient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Poor quality product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-